We are live on ! Find out more
CLYM

Climb Bio
CLYM

69 hedge funds and large institutions have $61.9M invested in Climb Bio in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $63.4M → $61.9M (-$1.5M)

3.13% less ownership

Funds ownership: 76.97% → 73.83% (-3.1%)

9% less funds holding

Funds holding: 76 → 69 (-7)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
19
Reduced
23
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$626K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$604K
3
NFT
Nan Fung Trinity
Hong Kong
+$577K
4
Millennium Management
Millennium Management
New York
+$519K
5
SC
Shay Capital
New York
+$268K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.77M
2
NFGH
Nan Fung Group Holdings
Hong Kong
-$566K
3
SSA
Schonfeld Strategic Advisors
New York
-$540K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$451K
5
State Street
State Street
Massachusetts
-$343K
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
51
HSBC Holdings
United Kingdom
$16.2K -$4.27K -3,430 -21%
Deutsche Bank
52
Deutsche Bank
Germany
$15.4K +$15.4K +12,382 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$9.51K +$2.37K +1,906 +33%
Bank of America
54
Bank of America
North Carolina
$9.46K -$36.9K -29,660 -80%
Fidelity Investments
55
Fidelity Investments
Massachusetts
$9.46K +$6.19K +4,977 +188%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$4K -$2.17K -1,744 -38%
Mirae Asset Global Investments
57
Mirae Asset Global Investments
South Korea
$3.24K +$449 +361 +16%
Carson Wealth (CWM LLC)
58
Carson Wealth (CWM LLC)
Nebraska
$3K +$482 +387 +19%
GFM
59
GF Fund Management
China
$2K – – –
Nisa Investment Advisors
60
Nisa Investment Advisors
Missouri
$711 +$713 +573 New
PD
61
Point72 (DIFC)
United Arab Emirates
$522 +$524 +421 New
Osaic Holdings
62
Osaic Holdings
Arizona
$360 +$367 +295 New
Wells Fargo
63
Wells Fargo
California
$303 -$21.4K -17,205 -99%
Raymond James Financial
64
Raymond James Financial
Florida
$248 +$249 +200 New
EP
65
Essential Partners
California
$78 +$78 +63 New
EWA
66
EverSource Wealth Advisors
Alabama
$63 +$52 +42 +467%
TWD
67
True Wealth Design
Ohio
$24 +$9 +7 +58%
SS
68
SBI Securities
Japan
$15 +$2 +2 +20%
CA
69
Clearstead Advisors
Ohio
$14 +$14 +11 New
NFGH
70
Nan Fung Group Holdings
Hong Kong
– -$566K -463,654 Closed
SSA
71
Schonfeld Strategic Advisors
New York
– -$540K -442,661 Closed
AI
72
Allostery Investments
Connecticut
– -$299K -244,988 Closed
IC
73
Ikarian Capital
Texas
– -$214K -175,088 Closed
BCM
74
Boxer Capital Management
California
– -$177K -145,000 Closed
Charles Schwab
75
Charles Schwab
California
– -$85.5K -70,093 Closed
1 2
3
4

CLYM Hedge Fund Activity: Q2 2025 in Review

69 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q2 2025, worth a combined $61.9M — down 2.4% from $63.4M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CLYM and 19 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 19 added.

The largest buyer was Cantor Fitzgerald, adding an estimated $626K. The largest seller was BlackRock, cutting an estimated $1.77M.

  • 69 institutional investors held Climb Bio (CLYM) as of Q2 2025, down from 76 in Q1 2025.
  • Funds reported $61.9M of Climb Bio stock for Q2 2025, down 2.4% quarter-over-quarter.
  • 19 funds opened new Climb Bio positions in Q2 2025 and 26 closed out, a net change of -7 holders.
  • The largest Climb Bio buyer in Q2 2025 was Cantor Fitzgerald, an estimated $626K added.
  • The largest Climb Bio seller in Q2 2025 was BlackRock, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2025.